Instuitional Investor - Arch Venture Corp

13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Maze Therapeutics Inc.	MAZE	4,120,053	$122,983,582	18.16%
2.	Rapport Therapeutics Inc.	RAPP	3,728,738	$116,672,212	17.23%
3.	Vir Biotechnology Inc.	VIR	12,916,663	$115,733,300	17.09%
4.	Erasca Inc.	ERAS	7,091,557	$114,741,392	16.95%
5.	Beam Therapeutics Inc.	BEAM	4,540,132	$108,191,346	15.98%